Research

Energy balance

Only 2 out of 41 studies (approximately 5%) reported or assessed dietary intake or evaluated diet changes secondary to GLP-1/GIP RA medication use.

Practitioners should be aware of the lack of dietary assessment in studies involving GLP-1/GIP medications.

StrongSupportsmedium confidence
Only 2/41 studies (≈5%) reported or assessed dietary intake or evaluated diet changes secondary to GLP-1/GIP RA medication use.
A. Jansson et al. · Obesity Reviews · 2026

Why this rating

Based on the systematic review of randomized controlled trials.

Source

A Systematic Review Identifying Critical Evidence Gaps in Reporting Dietary Change in Randomized Controlled Trials Prescribing Liraglutide, Semaglutide, or Tirzepatide

A. Jansson et al. · Obesity Reviews · 2026

DOI 10.1111/obr.70077

systematic_review · n=50690Cited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →